Literature DB >> 25107578

Effects of exercise rehabilitation on cardiac electrical instability assessed by T-wave alternans during ambulatory electrocardiogram monitoring in coronary artery disease patients without and with diabetes mellitus.

Tuomas Kenttä1, Mikko P Tulppo2, Bruce D Nearing3, Jaana J Karjalainen4, Arto J Hautala5, Antti M Kiviniemi5, Heikki V Huikuri6, Richard L Verrier7.   

Abstract

Effects of exercise rehabilitation on electrocardiographic markers of risk for sudden cardiac death have not been adequately studied. We examined effects of controlled exercise training on T-wave alternans (TWA) in 24-hour ambulatory electrocardiogram recordings in patients with stable coronary artery disease (CAD) without and with type 2 diabetes mellitus (DM). Consecutive patients with angiographically confirmed CAD were recruited to join the ARTEMIS (Innovation to Reduce Cardiovascular Complications of Diabetes at the Intersection) study. Exercise (n = 65) and control groups (n = 65) were matched on age, sex, DM, and previous myocardial infarction. Ambulatory electrocardiograms were recorded before and after a 2-year training period. TWA was assessed using time domain-modified moving average method by an investigator blinded to patients' clinical status. Average TWA values decreased in the rehabilitation group but not in control patients (rehabilitation [mean ± SEM]: 52.8 ± 1.7 μV vs 48.7 ± 1.5 μV, p <0.001; control: 53.7 ± 1.7 μV vs 54.3 ± 1.6 μV, p = 0.746). Changes in TWA differed between the groups (rehabilitation: -4.1 ± 1.2 μV vs controls: +0.6 ± 1.1 μV, p = 0.005). In CAD + DM patients, 50% (n = 9) of the 18 positive TWA cases were converted with exercise versus 10% (n = 2 of 20) of controls (p = 0.020). In CAD patients, 30% (n = 8 of 27) of positive TWA cases were converted with exercise versus 4% (n = 1 of 28) of controls (p = 0.012). In conclusion, this is the first report of the effectiveness of exercise rehabilitation to reduce TWA, a marker of sudden cardiac death risk, in patients with stable CAD.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 25107578     DOI: 10.1016/j.amjcard.2014.06.014

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  5 in total

1.  Microvolt T-wave Alternans: Where Are We Now?

Authors:  Aapo L Aro; Tuomas V Kenttä; Heikki V Huikuri
Journal:  Arrhythm Electrophysiol Rev       Date:  2016-05

2.  2017 ISHNE-HRS expert consensus statement on ambulatory ECG and external cardiac monitoring/telemetry.

Authors:  Jonathan S Steinberg; Niraj Varma; Iwona Cygankiewicz; Peter Aziz; Paweł Balsam; Adrian Baranchuk; Daniel J Cantillon; Polychronis Dilaveris; Sergio J Dubner; Nabil El-Sherif; Jaroslaw Krol; Malgorzata Kurpesa; Maria Teresa La Rovere; Suave S Lobodzinski; Emanuela T Locati; Suneet Mittal; Brian Olshansky; Ewa Piotrowicz; Leslie Saxon; Peter H Stone; Larisa Tereshchenko; Mintu P Turakhia; Gioia Turitto; Neil J Wimmer; Richard L Verrier; Wojciech Zareba; Ryszard Piotrowicz
Journal:  Ann Noninvasive Electrocardiol       Date:  2017-05       Impact factor: 1.468

3.  Effect of cardiac shock wave therapy on the microvolt T wave alternans of patients with coronary artery disease.

Authors:  Ling Zhao; Ping Yang; Yaming Tang; Ruijie Li; Yunzhu Peng; Yu Wang; Lijin Pu; Tao Guo
Journal:  Int J Clin Exp Med       Date:  2015-09-15

4.  Benefits of cardiac rehabilitation following acute coronary syndrome for patients with and without diabetes: a systematic review and meta-analysis.

Authors:  Birgitte Bitsch Gadager; Lars Hermann Tang; Maiken Bay Ravn; Patrick Doherty; Alexander Harrison; Jan Christensen; Rod S Taylor; Ann-Dorthe Zwisler; Thomas Maribo
Journal:  BMC Cardiovasc Disord       Date:  2022-06-27       Impact factor: 2.174

5.  Novel method to assess intrinsic heart rate recovery in ambulatory ECG recordings tracks cardioprotective effects of chronic autonomic regulation therapy in patients enrolled in the ANTHEM-HF study.

Authors:  Gerrard M Carlson; Imad Libbus; Badri Amurthur; Bruce H KenKnight; Richard L Verrier
Journal:  Ann Noninvasive Electrocardiol       Date:  2017-02-17       Impact factor: 1.468

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.